These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18776262)

  • 1. Development of A3 adenosine receptor ligands.
    Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):79-80. PubMed ID: 18776262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
    Jeong LS; Choe SA; Gunaga P; Kim HO; Lee HW; Lee SK; Tosh DK; Patel A; Palaniappan KK; Gao ZG; Jacobson KA; Moon HR
    J Med Chem; 2007 Jul; 50(14):3159-62. PubMed ID: 17555308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topological descriptors in modeling the agonistic activity of human A3 adenosine receptor ligands: the derivatives of 2-chloro-N(6)-substituted-4'-thioadenosine-5'-uronamide.
    Sharma S; Sharma BK; Sharma SK; Singh P; Prabhakar YS
    Eur J Med Chem; 2009 Apr; 44(4):1377-82. PubMed ID: 18973967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional drug design: simultaneous analysis of binding and relative efficacy profiles of N(6)-substituted-4'-thioadenosines A3 adenosine receptor agonists.
    Cruz-Monteagudo M; Cordeiro MN; Teijeira M; González MP; Borges F
    Chem Biol Drug Des; 2010 Jun; 75(6):607-18. PubMed ID: 20408851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-4'-thioadenosine derivatives as highly potent and selective agonists at the human A3 adenosine receptor.
    Lee HW; Shin DH; Jeong JY; Kim HO; Chun MW; Melman N; Gao ZG; Jacobson KA; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):607-9. PubMed ID: 16247997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.
    Jeong LS; Jin DZ; Kim HO; Shin DH; Moon HR; Gunaga P; Chun MW; Kim YC; Melman N; Gao ZG; Jacobson KA
    J Med Chem; 2003 Aug; 46(18):3775-7. PubMed ID: 12930138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
    Jeong LS; Pal S; Choe SA; Choi WJ; Jacobson KA; Gao ZG; Klutz AM; Hou X; Kim HO; Lee HW; Lee SK; Tosh DK; Moon HR
    J Med Chem; 2008 Oct; 51(20):6609-13. PubMed ID: 18811138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors.
    Lee HW; Kim HO; Choi WJ; Choi S; Lee JH; Park SG; Yoo L; Jacobson KA; Jeong LS
    Bioorg Med Chem; 2010 Oct; 18(19):7015-21. PubMed ID: 20826090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of truncated 4'-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists.
    Hou X; Pal S; Choi WJ; Kim HO; Tipnis A; Jacobson KA; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):641-2. PubMed ID: 18776543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
    Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and anti-tumor activity of 4'-thionucleosides as potent and selective agonists at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Kim HO; Jung JY; Gunaga P; Lee SK; Lee EJ; Chun MW; Gao ZG; Jacobson KA; Moon HR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1565-8. PubMed ID: 18066827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of potent and selective human A3 adenosine receptor agonists.
    Jeong LS; Lee HW; Jacobson KA; Lee SK; Chun MW
    Nucleic Acids Symp Ser (Oxf); 2005; (49):31-2. PubMed ID: 17150618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
    Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
    Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
    Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
    Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptor.
    DeNinno MP; Masamune H; Chenard LK; DiRico KJ; Eller C; Etienne JB; Tickner JE; Kennedy SP; Knight DR; Kong J; Oleynek JJ; Tracey WR; Hill RJ
    Bioorg Med Chem Lett; 2006 May; 16(9):2525-7. PubMed ID: 16464581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A3 adenosine receptor: an enigmatic player in cell biology.
    Gessi S; Merighi S; Varani K; Leung E; Mac Lennan S; Borea PA
    Pharmacol Ther; 2008 Jan; 117(1):123-40. PubMed ID: 18029023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
    Panjehpour M; Karami-Tehrani F
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1502-9. PubMed ID: 15147729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2-alkynyl substituted 4'-thioadenosine derivatives and their binding affinities at the adenosine receptors.
    Liang CW; Choi WJ; Jeong LS
    Arch Pharm Res; 2008 Aug; 31(8):973-7. PubMed ID: 18787783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.